Document is current

Article History

Received: 9 February 2026

Accepted: 19 March 2026

First Online: 24 March 2026

Declarations

:

: Not applicable.

: Not applicable.

: CM reports speakers’ honoraria from UCB, outside of the submitted work. SSB reports honoraria and research funding from Angelini Pharma, Biocodex, Desitin Arzneimittel, Eisai, Longboard, Jazz Pharmaceuticals, Takeda, and UCB Pharma. F. Rosenow reports personal fees from Angelini Pharma, Desitin Pharma, Eisai GmbH, and UCB Pharma and grants from the Detlev-Wrobel-Fonds for Epilepsy Research, the Deutsche Forschungsgemeinschaft (DFG), the Federal Ministry of Education and Research (BMBF), the LOEWE Program of the State of Hesse, and the European Union, and from the Dr Senckenbergische Stiftung, the Reiss Stiftung, and the Ernst Max von Grunelius Foundation Frankfurt.edical. AS reports honoraria and research funding from Angelini Pharma, Biocodex, Desitin Arzneimittel, Eisai, Longboard, Jazz Pharmaceuticals, Neuraxpharm, Takeda, Stoke Therapeutics, UCB Pharma and UNEEG Medical. A Strzelczyk is on the editorial board of Neurological Research and Practice.